Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.

C François1, R van Velthoven, O De Lathouwer

  • 1Laboratory of Histology, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.

American Journal of Clinical Pathology
|August 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Leptosira concentrations in two rivers within contrasting catchments in a leptospirosis hotspot.

Journal of contaminant hydrology·2026
Same author

Efficacy and safety of dupilumab in Hailey-Hailey disease: A multicentre cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Mammary and extramammary diffuse dermal angiomatosis: a case series and review of the literature.

Annales de dermatologie et de venereologie·2025
Same author

Leser-Trélat sign on BRAF inhibitors.

Annales de dermatologie et de venereologie·2025
Same author

[Role of nurses specializing in oncology to support the care journey for patients with penile cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same author

Comment to the article "Standing tests lack reliability to diagnose all adolescents who have postural tachycardia syndrome".

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2023

Galectins, not the T antigen, are linked to worsening renal cell carcinoma (RCC). Changes in galectin-1 and galectin-3 expression correlate with increased RCC aggressiveness and poor patient prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The roles of galectins and the Thomsen-Friedenreich (T) antigen in renal cell carcinoma (RCC) progression are largely unknown.
  • Galectins are a significant class of glycoproteins implicated in various cellular processes.

Purpose of the Study:

  • To investigate the expression levels of galectin-1, galectin-3, and their binding sites in RCC.
  • To assess the expression of the T antigen and its binding sites in relation to RCC clinical outcomes.
  • To determine the association between galectin and T antigen expression and RCC aggressiveness.

Main Methods:

  • Quantitative analysis of galectin-1, galectin-3, laminin, and T antigen expression using computer-assisted microscopy.
  • Immunohistochemical and glycohistochemical staining of 74 RCC samples.

Related Experiment Videos

  • Correlation of molecular marker expression with clinical outcomes and tumor grade.

    • Main Results:

    • Elevated galectin-3 heterogeneity or low galectin-1 binding sites correlated with unfavorable prognoses in grade II/III RCC.
    • T antigen expression and binding sites showed no significant changes between RCC groups with different clinical outcomes.
    • Modifications in galectin-1 and galectin-3 expression, unlike T antigen, paralleled increased RCC aggressiveness.

    Conclusions:

    • Galectins play a significant role in the progression of renal cell carcinoma.
    • Galectin-1 and galectin-3 expression levels serve as potential indicators of RCC aggressiveness and patient prognosis.
    • The T antigen does not appear to be a significant factor in RCC progression or clinical outcome.